Patents
More topics under "A61K - Preparations for medical, dental, or toilet purposes" (2,585,043)
A61K 101 - Radioactive non-metals (526)
A61K 103 - Radioactive metals (481)
A61K 125 - Containing or obtained from roots, bulbs, tubers, corms or rhizomes (2,645)
A61K 127 - Containing or obtained from leaves (1,806)
A61K 129 - Containing or obtained from bark (325)
A61K 131 - Containing or obtained from seeds, nuts, fruits or grains (1,932)
A61K 133 - Containing or obtained from flowers or blossoms (665)
A61K 135 - Containing or obtained from stems, stalks, branches, twigs or shoots (756)
A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316)
A61K 38 - Medicinal preparations containing peptides (316,240)
A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
A61K 49 - Preparations for testing in vivo (35,376)
A61K 50 - Electrically conductive preparations for use in therapy or testing in vivo, e.g. conductive adhesives or gels to be used with electrodes for electrocardiography (ecg) or for transcutaneous drug administration (62)
A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
A61K 6 - Preparations for dentistry (18,259)
A61K 8 - Cosmetics or similar toilet preparations (170,551)
A61K 9 - Medicinal preparations characterised by special physical form (299,044)
Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449)
04/2004
04/21/2004CN1490056A Immune method and composition for HIV-1
04/21/2004CN1490016A Bougie for treating virus hepatitis and preparing method thereof
04/21/2004CN1146429C Phospholipid complexes of proanthocyanidin A2 used as antiatherosclerotic agent
04/21/2004CN1146427C Solid oral dosage form comprising combination of metformin and glibenclamide
04/21/2004CN1146410C Controlled release formulation
04/21/2004CN1146394C Dual component dentifrice composition for dental fluoridation
04/20/2004US6723726 Protein tyrosine kinase inhibitors
04/20/2004US6723719 Dysmenorrhoea, benign prostatic hyperplasia (bph), bladder outlet obstruction, incontinence, agina, congestive heart failure, atherosclerosis; hypotensive and antiallergen agents
04/15/2004WO2004031356A2 Recombinant intracellular pathogen immunogenic compositions and methods for use
04/15/2004WO2004030636A2 Human papillomavirus polypeptides and immunogenic compositions
04/15/2004WO2004030634A2 Therapeutic compositions
04/15/2004WO2004030631A2 Anti-cancer and anti-infectious disease compositions and methods for using same
04/15/2004WO2004030623A2 Nitroxide radioprotector formulations and methods of use
04/15/2004WO2004030622A2 Method of isolation and self-assembly of small protein particles from blood and other biological materials
04/15/2004WO2004030614A2 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
04/15/2004WO2004030612A2 Light emitting diode, support & method of manufacture
04/15/2004WO2004030457A1 Nodulisporic acid derivative spot-on formulations for combating parasites
04/15/2004WO2003043580A3 Methods for identifying and validating potential drug targets
04/15/2004WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof
04/15/2004WO2002061052A8 An improved in vitro method of culturing mammalian cells for autologous cell implantation/transplantation methods
04/15/2004US20040072894 Anticholesterol agents; compressed into tablets
04/15/2004US20040072891 Urogenital disorders
04/15/2004US20040072880 Cycloalkyl inhibitors of potassium channel function
04/15/2004US20040072831 Reverse-turn mimetics and method relating thereto
04/15/2004US20040072748 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
04/15/2004US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases
04/15/2004US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides
04/15/2004US20040072138 Attenuation of ischemia/reperfusion injury
04/15/2004US20040071767 NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
04/15/2004US20040071693 Humanised antibodies
04/15/2004US20040071658 Vaccine immunotherapy for immune suppressed patients
04/15/2004CA2501981A1 Nitroxide radioprotector formulations and methods of use
04/15/2004CA2500822A1 Nodulisporic acid derivative spot-on formulations for combating parasites
04/15/2004CA2500661A1 Anti-cancer and anti-infectious disease compositions and methods for using same
04/15/2004CA2500433A1 Recombinant intracellular pathogen immunogenic compositions and methods for use
04/15/2004CA2499837A1 Human papillomavirus polypeptides and immunogenic compositions
04/15/2004CA2498823A1 Vaccines containing viruses involved in avian malabsorption syndrome and methods of administration therefor
04/14/2004EP1407008A2 Influenza vaccine composition
04/14/2004EP1406873A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
04/14/2004EP1406870A1 Taxol enhancer compounds
04/14/2004EP1406869A1 Taxol enhancer compounds
04/14/2004EP1406662A1 Pharmaceutical formulation for the intramuscular administration of fulvestrant
04/14/2004EP1028110B1 Novel dihydronaphthalene compounds and process for producing the same
04/14/2004EP0927040B1 Process to obtain oestrogens from mare's urine
04/14/2004EP0724561B1 Calcium receptor-active arylalkyl amines
04/14/2004CN1489592A 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias
04/14/2004CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof
04/14/2004CN1489588A Thiazolyl-oxazolyl-pyrrolyl-and imidazolyl-acid amide derivatives useful as inbibitors of PDE 4 isozymes
04/14/2004CN1489472A Improved mycoplasma hyopneumoniae bacterin vaccine
04/14/2004CN1488353A Composition for treating ischemic disease
04/14/2004CN1145643C Oligosaccharide mixtures having antithrombotic activity
04/14/2004CN1145486C Pharmaceutical compositions containing eletriptan hemisulphate and coffeine
04/14/2004CN1145478C Pharmaceutical aerosol formulation
04/14/2004CN1145473C Keratin fibers oxidation dyeing composition and dyeing method using same
04/13/2004US6720336 4,4-biarylpiperidine derivatives
04/13/2004US6720009 Matrix protein compositions for treating infection
04/08/2004WO2004029034A1 Synthesis of thiophenecarboxylic acid esters for the production of ranelic acid salts
04/08/2004WO2004028521A2 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
04/08/2004WO2004028509A1 Sustained released delivery of amphetamine salts
04/08/2004WO2004028481A2 Nucleoside derivatives for treating hepatitis c virus infection
04/08/2004WO2004028479A2 Nouvelles compositions et methodes de traitement du psoriasis
04/08/2004WO2004028478A2 Functional mutations in respiratory syncytial virus
04/08/2004WO2004028476A2 Artemisinin-derived trioxane dimers
04/08/2004WO2004028473A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
04/08/2004WO2004028472A2 THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β
04/08/2004WO2004028466A2 Ketoamide inhibitors in chronic nerve disease
04/08/2004WO2004028464A2 Methods and compositions for modification of splicing of pre-mrna
04/08/2004WO2004028463A2 Methods and compositions for the treatment of lupus using clofarabine
04/08/2004WO2004028460A2 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
04/08/2004WO2004028458A2 Antisense modulation of microsomal prostaglandin e2 synthase expression
04/08/2004WO2004028452A2 Method for preparing crambescidin core acid intermediates and their use for preparing crambescidin alkaloid analogs as therapeutic agents
04/08/2004WO2004028444A2 Parathyroid hormone antagonists and uses thereof
04/08/2004WO2004012658A3 Method and device for protein delivery into cells
04/08/2004WO2004000205A3 Novel tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
04/08/2004WO2003022123A9 Methods of kidney transplantation utilizing developing nephric tissue
04/08/2004US20040067940 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
04/08/2004US20040067921 Anticholesterol agents
04/08/2004US20040067875 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use
04/08/2004US20040067245 Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin
04/08/2004US20040067235 Methods for the use of neurotoxin in the treatment of urologic disorders
04/08/2004CA2503510A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations
04/08/2004CA2500189A1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-.beta.
04/08/2004CA2500091A1 Methods and compositions for the treatment of lupus using clofarabine
04/08/2004CA2499880A1 Methods and compositions for modification of splicing of pre-mrna
04/08/2004CA2499843A1 Novel compositions and methods for the treatment of psoriasis
04/08/2004CA2499253A1 Nucleoside derivatives for treating hepatitis c virus infection
04/08/2004CA2499042A1 Functional mutations in respiratory syncytial virus
04/08/2004CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome
04/07/2004EP1405852A1 Diamine derivatives
04/07/2004EP1404667A1 Piperidine derivatives useful as modulators of chemokine receptor activity
04/07/2004EP1404651A1 Process for the preparation 3-aryl-2-hydroxypropionic acid derivative
04/07/2004EP1404345A2 Skin-permeable selective cyclooxygenase-2 inhibitor composition
04/07/2004EP1404309A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl] propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug
04/07/2004EP1150991B1 Compositions for treating inflammatory response
04/07/2004EP1052997B1 Compositions comprising d-chiro-inositol for treating metabolic diseases characterized by hyperandrogenism and/or anovulation
04/07/2004EP0596032B2 Induction of cytotoxic t-lymphocyte responses
04/07/2004CN1487933A Pyrazole compounds useful as protein kinase inhibitors
04/07/2004CN1486698A Solid oral preparation containing melbine and Glibenclamide
04/07/2004CN1144805C Bridged bispidine compounds, its preparing method and intermediate and use for treatment of cardiac arrhythmias
04/06/2004US6716446 Medicament against dysmenorrhoea and premenstrual syndrome